The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab tests, according to a new study.
Jan 26, 2022
0
54
Yang Wang, MD, Ph.D., professor of medicine and deputy director of product discovery at MassBiologics of UMass Chan Medical School, leads a team of scientists working to discover and develop antibody-based medicines for infectious ...
Jan 24, 2022
0
17
Several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the omicron variant now sweeping across the United States, ...
Jan 21, 2022
2
146
Researchers at UBC's faculty of medicine have conducted the world's first molecular-level structural analysis of the Omicron variant spike protein. The findings were published today in Science.
Jan 20, 2022
1
236
While the omicron variant continues to infect people around the world, researchers at the University of Missouri have identified the highly prevalent, specific mutations that are causing the omicron variant's high rate of ...
Jan 20, 2022
0
5
US biotech firm Regeneron said Tuesday that its synthetic antibody treatment for COVID-19 may be less effective against the new variant, and it plans to conduct tests to determine by how much.
Nov 30, 2021
0
4
Accurately assessing the exposure of a population to a particular virus is difficult because the tools for doing so do not account for the fact that many viruses comprise multiple circulating strains, or the fact that people ...
Nov 24, 2021
1
39
Cross-protective antibodies from dengue and Zika last far longer than previously thought, scientists have found in a massive study involving more than 4,000 children in Nicaragua.
A synthetic antibody treatment developed by Regeneron reduced the risk of developing symptomatic COVID by more than 80 percent up to eight months after receiving the treatment, the US biotech firm said Monday.
Nov 8, 2021
0
9
Medical researchers have outlined a strategy to generate future-proofed COVID-19 vaccines that can resist emergent new viral strains.
Nov 2, 2021
0
19
